Remove 2021 Remove Healthcare Provider Remove Prescription
article thumbnail

Value-based healthcare can help reduce costs

World of DTC Marketing

According to the Kaiser Family Foundation (KFF), in 2021, the average cost of employee health insurance premiums for family coverage increased by 4% from the previous year to $22,221. Why haven’t more employers addressed the rising costs of employee healthcare with value-based care? employers during June and July 2021.

article thumbnail

What Pear Therapeutics’ Bankruptcy Has Left the DTX Industry to Ponder

MedCity News

Bringing the very first prescription digital therapeutic (PDT) to market in 2017, Pear Therapeutics went above and beyond to follow suggested regulatory guidelines, obtained Food & Drug Administration (FDA) clearance, and provided solid clinical study evidence. million increase over 2021. Nearly 20% of U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Sorry, the Inflation Bill won’t lower healthcare costs

World of DTC Marketing

It’s no wonder that voters consistently rank bringing down prescription drug prices and other measures to reduce the cost of care as among Congress’ top priorities. Congress rightly chose to negioate drug prices for Medicare, but prescription drugs are only 10-12% of every healthcare dollar we spend.

article thumbnail

New Prescription Migraine Drugs Aren’t Resonating with Patients—Here’s How Pharma Can Boost Uptake

PM360

Despite a slew of prescription options and widespread advertising pushes, most patients are sticking with over-the-counter (OTC) remedies rather than trying new preventive medications, according to Phreesia Life Sciences’ survey results collected from more than 4,000 patients checking in for their doctors’ appointments in July 2021.

article thumbnail

Prescribing shift for Pfizer’s Paxlovid expands access but draws questions

Pharmaceutical Technology

They will [check] new prescriptions for appropriateness and accuracy and that doesn't really change based on who's prescribing it.”. And, if there are concerns, the pharmacist can call their healthcare provider to develop a plan. Still, pharmacists having prescription authority is not without precedence, Ganio says.

article thumbnail

Marketing to Type 2 Diabetes Patients: How Pharma Can Increase Treatment Awareness, Improve Outcomes

PM360

Data collected by Phreesia Life Sciences in December 2021 and January 2022 from more than 4,000 adults diagnosed with or treated for type 2 diabetes as they checked in for their doctors’ appointments offers insights into how to most effectively reach these patients.

article thumbnail

Understanding a rare disease through the lens of real world and prevalence data

Clarivate

The REALITY study conducted in the United States, France, Italy, Spain and the United Kingdom in 2021 reported a distribution of ND4 (61%), ND6 (20%) and ND1 (18%) [6]. annually in the claims dataset for the period of 2018-2021. 9; 9/2021; p2461; DOI:10.1007/s00417-020-04993-1 [2] Ueda K et al. The Clarivate U.S.